Welcome to our dedicated page for KNEAT COM news (Ticker: KSIOF), a resource for investors and traders seeking the latest updates and insights on KNEAT COM stock.
kneat.com, inc. develops digital validation and quality process automation software for highly regulated industries. Its Kneat Gx platform is used to manage validation disciplines end to end, with compliance features tied to GxP environments, data integrity, 21 CFR Part 11/Annex 11 requirements, and ISO 9001 and ISO 27001 certification.
Company news commonly covers customer agreements with life sciences, CDMO, pharmaceutical packaging, and biopharma manufacturing organizations; financial results and shareholder communications; platform capabilities including optional AI tools; and the company’s State of Validation research on digitization, validation workload, and compliance practices.
Kneat (OTCQX: KSIOF) has been acquired by an affiliate of private equity firm Thoma Bravo in an all-cash transaction valued at approximately C$650 million. The deal, first announced on June 8, 2026, was overwhelmingly approved at Kneat’s Special Meeting of Shareholders on July 30, 2026.
With closing on August 11, 2026, Kneat shareholders (other than the Rolling Shareholder) are entitled to receive C$6.50 in cash per share. Kneat shares have ceased trading and will be delisted from the Toronto Stock Exchange as the company becomes privately held under Thoma Bravo’s ownership, which plans to support the expansion of Kneat’s digital validation platform Kneat Gx for life sciences and other highly regulated industries.
Kneat (TSX: KSI, OTCQX: KSIOF) announced that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement under which an affiliate of Thoma Bravo will acquire all outstanding Kneat common shares, other than rollover shares.
According to Kneat, completion of the transaction remains subject to satisfaction or waiver of the remaining conditions in the June 8, 2026 arrangement agreement, and closing is anticipated on or about August 11, 2026. Kneat provides the Kneat Gx digital validation platform for highly regulated industries, which customer studies indicate can reduce validation documentation man-hours and review/approval cycle times by up to 50%, while supporting higher regulatory compliance standards.
Kneat (TSX: KSI, OTCQX: KSIOF) announced that shareholders overwhelmingly approved the previously announced plan of arrangement under which Kneat will be acquired by an affiliate of Thoma Bravo. At the July 30, 2026 Special Meeting, approximately 87% of votes cast supported the transaction, including 84% of disinterested votes, satisfying the required special resolution threshold.
The deal remains subject to customary closing conditions, notably a Final Order from the Ontario Superior Court of Justice (Commercial List). The court hearing is scheduled for August 4, 2026, and, if approvals and conditions are met or waived, closing is anticipated shortly thereafter.
Kneat (OTCQX:KSIOF, TSX:KSI) filed and began mailing its management information circular for the proposed acquisition by a Thoma Bravo affiliate at C$6.50 per share in cash. The July 30, 2026 special meeting will ask shareholders to approve the deal, which values Kneat at an enterprise value of C$622 million.
The price represents a 40% premium to the May 8, 2026 close and 57%, 61% and 54% premia to the 30-, 60- and 90-day VWAPs. Kneat’s board unanimously recommends voting FOR the transaction.
Kneat (OTCQX:KSIOF, TSX:KSI) agreed to be acquired by an affiliate of Thoma Bravo in an all-cash deal valuing Kneat at about C$650 million.
Shareholders will receive C$6.50 per share, a premium of about 40% to May 8, 2026 and 20% to June 5, 2026 closing prices. The board unanimously supports the deal, which is expected to close in Q3 2026, after shareholder, court and regulatory approvals. Post-closing, Kneat will be private and its shares delisted from the TSX.
Kneat (OTCQX: KSIOF, TSX: KSI) reported voting results from its May 27, 2026 Annual General Meeting. All five director nominees were elected with support ranging from 96.61% to 99.98% of votes cast. Shareholders also re-appointed KPMG LLP as auditors with 99.99% support, with 51,419,056 votes cast overall.
Kneat (OTCQX:KSIOF) reported Q1 2026 revenue of $18.0 million, up 22% year over year. Gross profit rose 28% to $14.0 million, driving a 78% gross margin. ARR reached $76.4 million, up 20%.
The quarter showed a net loss of $3.9 million versus a prior-year profit, with EBITDA at $0.8 million and Adjusted EBITDA improving to $2.7 million. Kneat highlighted new life sciences customer wins, strong pipeline commentary, and recognition as a G2 leader in pharma and biotech software.
Kneat (TSX: KSI, OTC: KSIOF) acknowledged a press report about a potential strategic review and confirmed that its board has formed a special committee to evaluate strategic alternatives, with CIBC Capital Markets as financial advisor.
The review began in February 2026, and no definitive agreement or transaction has been reached. There is no assurance any transaction will occur. Kneat states it remains focused on its business strategy and shareholder value and does not plan further updates unless a definitive transaction is announced or disclosure becomes required.
Kneat Solutions (OTCQX: KSIOF) published its State of Validation 2026, based on over 600 validation professionals worldwide. The study finds rising validation workloads (80% increased; 45% significant), widespread digital tool adoption but limited full digital maturity (13% fully digital), and growing, human‑reviewed AI use in GxP settings.
Key metrics: 74% of implemented systems met or exceeded ROI expectations; 78% expect AI to be standard in validation by 2030. Paper remains common in core records.
kneat.com (OTCQX: KSIOF) signed a Master Subscription Agreement with one of Europe’s largest CDMOs to digitize equipment validation across more than two dozen production sites. The program targets stronger data integrity, traceability, standardization and improved audit readiness as the CDMO scales validation capacity.
The deal supports the CDMO’s corporate initiative to accelerate validation digitization driven by increased workload and a need for greater operational efficiency and scalability.